Progranulin Protein

Migration, Crosslink

📖

Progranulin Protein

active

wiki page Created: 2026-04-02T07:19:14 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-grn-protein

📖 Wiki Page

protein2203 wordssynced 2026-04-02

Progranulin Protein

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Progranulin Protein</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>[GRN](/genes/grn)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/P28799" target="_blank">P28799</a></td>
</tr>
<tr>
<td class="label">Length</td>
<td>593 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~63 kDa (full-length)</td>
</tr>
<tr>
<td class="label">Signal Peptide</td>
<td>Yes (1-18 aa)</td>
</tr>
<tr>
<td class="label">Localization</td>
<td>Secreted, lysosomes</td>
</tr>
<tr>
<td class="label">Family</td>
<td>Granulin family, Progranulin</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Frontotemporal Dementia](/diseases/ftd), [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/alzheimer-disease" style="color:#ef9a9a">Alzheimer Disease</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">339 edges</a></td>
</tr>
</table>

Progranulin Protein

Overview

...

Progranulin Protein

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Progranulin Protein</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>[GRN](/genes/grn)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/P28799" target="_blank">P28799</a></td>
</tr>
<tr>
<td class="label">Length</td>
<td>593 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~63 kDa (full-length)</td>
</tr>
<tr>
<td class="label">Signal Peptide</td>
<td>Yes (1-18 aa)</td>
</tr>
<tr>
<td class="label">Localization</td>
<td>Secreted, lysosomes</td>
</tr>
<tr>
<td class="label">Family</td>
<td>Granulin family, Progranulin</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Frontotemporal Dementia](/diseases/ftd), [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/alzheimer-disease" style="color:#ef9a9a">Alzheimer Disease</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">339 edges</a></td>
</tr>
</table>

Progranulin Protein

Overview

Progranulin (PGRN) is a secreted glycoprotein encoded by the [GRN gene](/genes/grn) that functions as a multifunctional growth factor and lysosomal regulator.[@progranulin2024] The protein plays critical roles in neuronal survival, microglial function, and protein homeostasis.[@microglial2019] Loss-of-function mutations in GRN cause [Frontotemporal Dementia (FTD)](/diseases/ftd) through haploinsufficiency, making progranulin a major therapeutic target.[@role2023]

Structure

Protein Architecture

Progranulin is a 593-amino acid secreted glycoprotein with a unique architecture:

N-terminal signal peptide (1-20 aa): Directs secretion via the secretory pathway
Granulin domain repeats (21-585 aa): 7.5 tandem repeats of a highly conserved 12-cysteine granulin domain
Each granulin domain: ~90 amino acids with 12 conserved cysteines forming 6 disulfide bonds

The crystal structure reveals that granulin domains fold into compact, cysteine-knot motifs that are highly resistant to proteolysis[^crystal2022]. Multiple granulin domains can stack together, creating a "beads-on-a-string" architecture.

Post-Translational Modifications

N-glycosylation: Multiple N-linked glycosylation sites in the granulin domains
Secretion: Processed through the secretory pathway and released as a full-length protein
Proteolytic processing: Cleaved by extracellular proteases (neutrophil elastase, proteinase 3, MMP-9) into functional granulin peptides (GRN A-G)[^proteolytic2021]

UniProt Information

UniProt ID: P28799
Molecular weight: ~63 kDa (full-length, unglycosylated)
Subcellular localization: Secreted, lysosomal lumen
Tissue specificity: High expression in brain (neurons, microglia), lung, kidney

Function

Normal Physiological Functions

Neuronal Survival Signaling

Progranulin promotes neuronal survival through multiple signaling pathways:

AKT activation: Progranulin binding to unidentified receptors activates PI3K/AKT signaling[^akt2020]

ERK/MAPK pathway: Progranulin stimulates ERK1/2 phosphorylation promoting neuronal viability

Neurotrophic effects: Supports neurite outgrowth and dendritic arborization

Lysosomal Function

Progranulin localizes to lysosomes where it:

Regulates cathepsin activity: Binds to and modulates lysosomal proteases
Maintains autophagic flux: Required for proper autophagosome-lysosome fusion[^lysosomal2017]
Coordinates trafficking: Associates with LAMP-2A in lysosomal membranes

Microglial Regulation

Progranulin modulates microglial function:

Anti-inflammatory: Reduces microglial activation and pro-inflammatory cytokine production
Phagocytosis regulation: Controls complement-mediated synaptic pruning[^complement2018]
Survival support: Promotes microglial viability under stress conditions

Protein Interactions

| Partner | Interaction Type | Functional Consequence |
|---------|-----------------|----------------------|
| Sortilin | Receptor-mediated endocytosis | Lysosomal targeting and degradation[^sortilin2020] |
| LAMP-2A | Lysosomal membrane association | Lysosomal trafficking |
| Cathepsins (B, D, L) | Protease binding | Lysosomal protease regulation |
| TDP-43 | Genetic interaction | Nuclear import regulation |

Role in Neurodegeneration

FTD Pathogenesis

GRN mutations cause FTD through haploinsufficiency—loss-of-function mutations reduce progranulin levels by ~50%, leading to:

TDP-43 pathology: Accumulation of hyperphosphorylated, ubiquitinated TDP-43 in cytoplasmic inclusions[^tdp432019]

Lysosomal dysfunction: Impaired autophagic flux and lipofuscin accumulation

Synaptic loss: Enhanced complement-mediated pruning by astrocytes[^complement2018]

Neuroinflammation: Dysregulated microglial activation[^microglial2019]

Disease Mechanisms

Mermaid diagram (expand to render)

Therapeutic Implications

Restoration Strategies

AAV gene therapy: AAV-mediated GRN delivery to restore progranulin expression[^progranulin2024]
Protein replacement: Recombinant progranulin administration
Small molecule upregulators: Compounds that increase GRN transcription

Inhibition of Degradation

Anti-sortilin antibodies: Block sortilin-mediated progranulin endocytosis and degradation[^sortilin2020]
Protease inhibitors: Prevent progranulin cleavage into granulin peptides

Clinical Significance

Biomarkers

CSF progranulin: Reduced in GRN mutation carriers; diagnostic for FTD
Plasma progranulin: Biomarker for monitoring treatment response
Neurofilament light chain (NfL): Elevated in GRN-FTD progression

Clinical Trials

Latozinemab (PRV-102): Anti-sortilin antibody to increase progranulin levels; Phase 1 completed 2024[^phase2024]
AAV-GRN (YL-001): Gene therapy for GRN-FTD; preclinical/Phase 1

Key Publications

[Progranulin: a growth factor for neurodegenerative diseases](https://doi.org/10.1038/s12276-024-01216-x). Experimental & Molecular Medicine. 2024.

[The role of progranulin in frontotemporal dementia](https://doi.org/10.1016/S1474-4422(23)00320-7). Lancet Neurology. 2023.

[Crystal structure of progranulin domains](https://doi.org/10.1038/s41594-022-00789-4). Nature Structural & Molecular Biology. 2022.

[Progranulin activates AKT and ERK signaling](https://doi.org/10.1007/s10571-020-00842-1). Cellular and Molecular Neurobiology. 2020.

[Progranulin deficiency leads to lysosomal dysfunction](https://doi.org/10.1038/nn.4628). Nature Neuroscience. 2017.

[TDP-43 pathology in frontotemporal dementia with GRN mutations](https://doi.org/10.1093/brain/awv219). Brain. 2015.

[Phase 1 study of latozinemab in progranulin-associated FTD](https://pubmed.ncbi.nlm.nih.gov/38356474/). Neurology. 2024.

External Links

[UniProt: P28799](https://www.uniprot.org/uniprot/P28799)
[NCBI Gene: GRN](https://www.ncbi.nlm.nih.gov/gene/2896)
[OMIM: 138945](https://omim.org/entry/138945)

References

[Unknown, Progranulin: a growth factor, a ternary ligand protein and an auspicious marker for neurodegenerative diseases (2024)](https://doi.org/10.1038/s12276-024-01216-x)

[Unknown, Crystal structure of progranulin domains reveals unique binding and regulatory features (2022)](https://doi.org/10.1038/s41594-022-00789-4)

[Unknown, Proteolytic processing of progranulin generates functional granulin peptides (2021)](https://doi.org/10.1074/jbc.RA120.015678)

[Unknown, Progranulin deficiency leads to lysosomal dysfunction and autophagy impairment (2017)](https://doi.org/10.1038/nn.4628)

[Unknown, Sortilin mediates the lysosomal degradation of progranulin (2020)](https://doi.org/10.1038/s41593-019-0562-5)

[Unknown, Loss of progranulin leads to TDP-43 pathology in mice (2019)](https://doi.org/10.1186/s13024-019-0320-x)

[Unknown, Progranulin activates AKT and ERK signaling pathways to promote neuronal survival (2020)](https://doi.org/10.1007/s10571-020-00842-1)

[Unknown, Progranulin deficiency promotes circuit-specific synaptic pruning by astrocytes via the complement C1q receptor (2018)](https://doi.org/10.1126/science.aad8964)

[Unknown, Microglial activation in progranulin-deficient brains (2019)](https://doi.org/10.1186/s40478-019-0740-4)

[Unknown, The role of progranulin in frontotemporal dementia and other neurodegenerative disorders (2023)]([DOI:10.1016/S1474-4422(23)00320-7](https://doi.org/10.1016/S1474-4422(23)00320-7))

[Unknown, AAV-mediated gene therapy for progranulin deficiency (2024)](https://doi.org/10.1016/j.ymthe.2024.01.015)

[Unknown, Phase 1 study of latozinemab in progranulin-associated frontotemporal dementia (2024)](https://pubmed.ncbi.nlm.nih.gov/38356474/)

Molecular Mechanisms

Granulin Peptide Generation

Progranulin is proteolytically processed into granulin peptides (granuins), each approximately 6 kDa[^proteolytic2021]:

Processing Enzymes:

Neutrophil elastase (ELANE)
Proteinase 3 (PRTN3)
Matrix metalloproteinase-9 (MMP-9)
Various lysosomal proteases

Granulin Peptides (GRN A-G):

GRN A: N-terminal granulin
GRN B-G: Internal repeats
Each peptide retains biological activity
Can function independently or in complex

Functional Implications:

Granulins have distinct activities from full-length PGRN
Some granulin peptides may be neurotoxic
Processing regulates progranulin function

Lysosomal Function

Progranulin plays critical roles in lysosomal homeostasis[^fallon2020]:

Lysosomal Enzyme Regulation:

Binds to and modulates cathepsin D
Affects cathepsin B and L activities
Maintains optimal lysosomal pH

Autophagy Regulation:

Required for proper autophagosome formation
Facilitates autophagosome-lysosome fusion
Maintains autophagic flux[^lysosomal2017]

Lipid Metabolism:

Affects lysosomal lipid composition
Influences membrane trafficking
Altered in progranulin deficiency

Signaling Pathways

PI3K/AKT Pathway[^akt2020]:

Progranulin activates AKT phosphorylation
Promotes neuronal survival
Neuroprotective effects

ERK/MAPK Pathway:

Stimulates ERK1/2 phosphorylation
Supports neurite outgrowth
Dendritic arborization

Wnt Signaling:

Cross-talk with Wnt pathway
Affects neuronal development
Implications for neurodegeneration

Structural Biology

Domain Architecture

Progranulin contains multiple functional domains:

Signal Peptide (1-18 aa):

Directs secretion via ER-Golgi pathway
Cleaved during maturation

Granulin Domains (21-585 aa):

7.5 tandem repeats of granulin domain
Each ~90 amino acids
12 conserved cysteines per domain

Cysteine Knot Motif:

Each granulin forms compact domain
Highly resistant to proteolysis
Multiple disulfide bonds

Crystal Structure Insights[^crystal2022]

The crystal structure reveals:

Granulin domains fold independently
Stack to form full-length protein
Multiple binding interfaces
Potential drug target sites

Brain Region-Specific Functions

Frontal and Temporal Cortex

Progranulin is essential for cortical function:

Neuronal Function:

Maintains cortical neuron viability
Regulates synaptic transmission
Affects executive function

Disease Implications:

Frontal cortex: Executive dysfunction
Temporal cortex: Language deficits
Progressive in FTD

Hippocampus

Hippocampal progranulin function[^zhao2022]:

Memory Function:

Supports hippocampal synaptic plasticity
Affects LTP and learning
Spatial memory regulation

Vulnerability:

Early hippocampal involvement in GRN-FTD
Memory deficits prominent
CA1 region particularly affected

Basal Ganglia

Progranulin in basal ganglia:

Regulates striatal neuron function
Affects motor control
Movement abnormalities in deficiency

Cerebellum

Cerebellar progranulin:

Purkinje cell function
Motor coordination
Potential ataxia in deficiency

Microglial Biology

Progranulin in Microglia[^butler2021]

Microglia are major producers and targets of progranulin:

Microglial Secretion:

Secreted in response to injury
Part of neuroinflammatory response
Autocrine and paracrine effects

Phagocytic Regulation:

Controls complement-mediated phagocytosis
Regulates synaptic pruning
Affects debris clearance[^complement2018]

Neuroinflammation

Progranulin modulates neuroinflammation:

Anti-inflammatory Effects:

Reduces pro-inflammatory cytokine production
Modulates microglial activation
Protective in injury models[^microglial2019]

In Deficiency:

Enhanced neuroinflammation
Increased cytokine release
Exacerbated pathology

Neurodevelopment

Developmental Expression[^chen2023]

Progranulin shows developmental regulation:

High expression during brain development
Critical for neuronal differentiation
Axon guidance effects

Critical Periods

Prenatal Development:

Neuronal proliferation
Migration patterns
Early circuit formation

Postnatal Development:

Synaptogenesis
Refinement of connections
Myelination support

Therapeutic Strategies

Protein Replacement

Recombinant Progranulin:

Full-length protein administration
Delivery challenges (blood-brain barrier)
Currently in preclinical development

Small Molecule Upregulators

Transcription Enhancement:

Compounds that increase GRN expression
Histone deacetylase inhibitors
Under investigation

Anti-Sortilin Therapy[^sortilin2020]

Latozinemab (PRV-102):

Monoclonal antibody against sortilin
Blocks progranulin uptake
Increases plasma progranulin[^phase2024]
Phase 1 trials completed

Gene Therapy

AAV-GRN Delivery:

AAV vector-mediated GRN delivery
Neuronal and microglial targeting
Preclinical studies ongoing

Combination Approaches

Targeting multiple pathways
Progranulin enhancement + downstream effects
Personalized medicine approaches

Biomarkers for GRN-FTD

Fluid Biomarkers

Plasma progranulin: Reduced in mutation carriers
CSF progranulin: Diagnostic utility
Neurofilament light chain (NfL): Disease progression

Imaging Biomarkers

MRI: Frontal/temporal atrophy patterns
PET: Neuroinflammation markers
Structural: Rate of progression

Clinical Biomarkers

Executive function tests
Language assessments
Behavioral inventories

Genetic Considerations

GRN Mutations

Mutation Types:

Loss-of-function mutations
Null alleles causing haploinsufficiency
Missense mutations with variable effects

Penetrance:

Nearly complete by age 80
Variable age of onset
Modifier genes influence phenotype

Genetic Testing

Indications:

Family history of FTD
Early-onset dementia
Atypical presentations

Interpretation:

Pathogenic variant confirmation
Genetic counseling importance
Family screening

Animal Models

Knockout Models

Grn-/- Mice:

Develop age-dependent phenotypes
Lysosomal abnormalities
Microglial activation
Behavioral deficits

Grn+/- Mice:

Partial deficiency model
Haploinsufficiency effects
Useful for therapeutic testing

Transgenic Models

Human GRN transgenic mice
Mutant GRN knock-in
Disease-mimicking models

Future Directions

Research Priorities

Mechanism elucidation: Detailed molecular pathways

Therapeutic development: Small molecules and biologics

Biomarker discovery: Early detection and monitoring

Clinical trials: Designing effective studies

Emerging Concepts

Epigenetic regulation: GRN expression control
Non-neuronal roles: Glial contributions
Network effects: Systems-level understanding
Precision medicine: Personalized approaches

Progranulin in Other Neurological Conditions

Alzheimer's Disease

While GRN mutations cause FTD, progranulin also plays roles in AD:

Reduced progranulin in AD brains
Possible interaction with amyloid pathology
May affect tau metabolism

Parkinson's Disease

GRN variants may modify PD risk:

Association with PD susceptibility
Possible interaction with α-synuclein
Therapeutic implications

Amyotrophic Lateral Sclerosis (ALS)

GRN mutations occasionally found in ALS
Overlapping TDP-43 pathology
Shared mechanistic pathways

Psychiatric Disorders

Schizophrenia: Altered progranulin levels
Depression: Inflammatory connection
Bipolar disorder: Possible role

Interaction Networks

Protein-Protein Interactions

| Partner | Interaction Type | Functional Consequence |
|---------|-----------------|----------------------|
| Sortilin | Receptor binding | Lysosomal targeting |
| LAMP-2A | Lysosomal association | Trafficking |
| Cathepsins | Protease binding | Activity regulation |
| TDP-43 | Genetic interaction | Nuclear-cytoplasmic transport |
| HSC70 | Chaperone binding | Processing |
| C1q | Complement receptor | Synaptic pruning |

Signaling Pathway Integration

Progranulin intersects with multiple pathways:

PI3K/AKT: Neuronal survival
ERK/MAPK: Growth and differentiation
NF-κB: Inflammation
Wnt: Development
Notch: Cell fate

Clinical Management

Diagnostic Approach

Clinical Evaluation:

Detailed neurological examination
Cognitive testing (executive, language)
Behavioral assessment

Genetic Testing:

Confirmed diagnosis
Family counseling
Prognostic information

Biomarkers:

Plasma/CSF progranulin
Neuroimaging
Neurofilament markers

Treatment Strategies

Symptomatic Management:

Behavioral interventions
Speech therapy
Occupational therapy

Disease-Modifying Approaches:

Anti-sortilin antibodies
Gene therapy
Small molecule upregulators

Supportive Care:

Caregiver support
Safety considerations
Quality of life optimization

Research Landscape

Ongoing Clinical Trials

Latozinemab (PRV-102): Phase 1 completed, planning Phase 2

AAV-GRN (YL-001): Preclinical development

Small molecule upregulators: Discovery phase

Preclinical Research

New mouse models
Mechanism studies
Drug delivery optimization

Future Directions

Biomarker validation
Combination therapy approaches
Personalized treatment strategies

Additional Clinical Considerations

Differential Diagnosis

GRN-FTD must be distinguished from:

Behavioral variant FTD: Primary behavioral presentation
Primary progressive aphasia: Language-predominant variant
AD with prominent behavior: Overlapping features
Psychiatric disorders: Depression, bipolar disorder

Disease Progression

Early Stage:

Subtle behavioral changes
Executive dysfunction
Preserved activities of daily living

Middle Stage:

Progressive personality changes
Language impairment
Motor symptoms emerging

Late Stage:

Severe cognitive decline
Motor impairment
Complete functional dependence

Quality of Life Considerations

Caregiver burden
Safety concerns (wandering, falls)
Communication strategies
End-of-life planning

📖 View canonical wiki page →

Related Entities

GRNPROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-grn-protein
kg_node_id	GRNPROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-3e08dadb3039
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-grn-protein'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

75%

Debates

0

Incoming

15

Outgoing

12

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Progranulin Protein

Progranulin Protein

Progranulin Protein

Overview

Progranulin Protein

Progranulin Protein

Overview

Structure

Protein Architecture

Post-Translational Modifications

UniProt Information

Function

Normal Physiological Functions

Neuronal Survival Signaling

Lysosomal Function

Microglial Regulation

Protein Interactions

Role in Neurodegeneration

FTD Pathogenesis

Disease Mechanisms

Therapeutic Implications

Restoration Strategies

Inhibition of Degradation

Clinical Significance

Biomarkers

Clinical Trials

Key Publications

See Also

External Links

References

Molecular Mechanisms

Granulin Peptide Generation

Lysosomal Function

Signaling Pathways

Structural Biology

Domain Architecture

Crystal Structure Insights[^crystal2022]

Brain Region-Specific Functions

Frontal and Temporal Cortex

Hippocampus

Basal Ganglia

Cerebellum

Microglial Biology

Progranulin in Microglia[^butler2021]

Neuroinflammation

Neurodevelopment

Developmental Expression[^chen2023]

Critical Periods

Therapeutic Strategies

Protein Replacement

Small Molecule Upregulators

Anti-Sortilin Therapy[^sortilin2020]

Gene Therapy

Combination Approaches

Biomarkers for GRN-FTD

Fluid Biomarkers

Imaging Biomarkers

Clinical Biomarkers

Genetic Considerations

GRN Mutations

Genetic Testing

Animal Models

Knockout Models

Transgenic Models

Future Directions

Research Priorities

Emerging Concepts

Progranulin in Other Neurological Conditions

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Psychiatric Disorders

Interaction Networks

Protein-Protein Interactions

Signaling Pathway Integration

Clinical Management

Diagnostic Approach

Treatment Strategies

Research Landscape